TET1 decreases in intrahepatic cholangiocarcinoma (ICC) and suppresses ICC progression by activating oncogenes through direct binding to oncogene promoters for demethylation [59]. This evidence concerns the gene TET1 and intrahepatic cholangiocarcinoma.